• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSOLUTE PRO VASCULAR SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSOLUTE PRO VASCULAR SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Catalog Number 1012535-100
Device Problems Device Damaged by Another Device (2915); Material Deformation (2976); Migration (4003)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/10/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The stent remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The 6.0x200 mm armada 18 and supera referenced are being filed under separate medwatch mfr numbers.
 
Event Description
It was reported that the 6.0 x 200 mm armada 18 was inflated for the first time at 8 atmospheres in the heavily calcified superficial femoral artery (sfa) without incident.A supera was implanted in the mid sfa followed by the 7.0x100 mm absolute pro vascular stent in the proximal/ostium sfa.The same armada 18 was inserted to post dilate a segment of the supera stent where three very fibrotic segments were observed to not completely yield.The armada 18 was inflated to 14 atmospheres when the balloon ruptured and separated in the anatomy.There was difficulty removing the ruptured armada past the absolute pro stent, resulting in the stent becoming smashed/deformed.The stent was also moved partially into healthy tissue during the attempt to remove the armada.A non-abbott diagnostic catheter was inserted to remove the separated armada segment.The fractured armada was successfully retracted into the tip of the sheath along with the guide wire that had some of the armada on it as well.All the devices were removed as a unit.There were no armada fragments left in the patient.A 7.0x20 mm absolute pro vascular stent was implanted in the ostium over the damaged segment of the first absolute stent.There was no adverse patient sequela.No additional information was provided.
 
Manufacturer Narrative
Internal file number: (b)(4).The product was not returned for analysis.A review of the lot history record and similar incident query could not be performed because the lot number was not provided.The investigation determined the reported difficulties of migration of the device, device damaged by another device and material deformation appear to be related to circumstances of the procedure.During removal of the ruptured balloon, resistance was felt with the absolute pro stent resulting in the stent to deform and to migrate from the intended location into healthy tissue.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO VASCULAR SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8298540
MDR Text Key134786641
Report Number2024168-2019-00778
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
PMA/PMN Number
P110028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1012535-100
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/10/2019
Initial Date FDA Received02/01/2019
Supplement Dates Manufacturer Received02/12/2019
Supplement Dates FDA Received02/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
STENT: SUPERA, BALLOON CATHETER: ARMADA 18; STENT: SUPERA, BALLOON CATHETER: ARMADA 18
Patient Outcome(s) Required Intervention;
Patient Age45 YR
-
-